These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 20391423)

  • 1. Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial.
    Friedman DM; Llanos C; Izmirly PM; Brock B; Byron J; Copel J; Cummiskey K; Dooley MA; Foley J; Graves C; Hendershott C; Kates R; Komissarova EV; Miller M; Paré E; Phoon CK; Prosen T; Reisner D; Ruderman E; Samuels P; Yu JK; Kim MY; Buyon JP
    Arthritis Rheum; 2010 Apr; 62(4):1138-46. PubMed ID: 20391423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the idiotype:antiidiotype antibody ratio with the efficacy of intravenous immunoglobulin treatment for the prevention of recurrent autoimmune-associated congenital heart block.
    Routsias JG; Kyriakidis NC; Friedman DM; Llanos C; Clancy R; Moutsopoulos HM; Buyon J; Tzioufas AG
    Arthritis Rheum; 2011 Sep; 63(9):2783-9. PubMed ID: 21618202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study.
    Pisoni CN; Brucato A; Ruffatti A; Espinosa G; Cervera R; Belmonte-Serrano M; Sánchez-Román J; García-Hernández FG; Tincani A; Bertero MT; Doria A; Hughes GR; Khamashta MA
    Arthritis Rheum; 2010 Apr; 62(4):1147-52. PubMed ID: 20131278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects.
    Clancy RM; Buyon JP; Ikeda K; Nozawa K; Argyle DA; Friedman DM; Chan EK
    Arthritis Rheum; 2005 Oct; 52(10):3079-86. PubMed ID: 16200587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal lupus: bedside to bench and back.
    Buyon JP
    Scand J Rheumatol; 1996; 25(5):271-6. PubMed ID: 8921918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers.
    Izmirly P; Kim M; Friedman DM; Costedoat-Chalumeau N; Clancy R; Copel JA; Phoon CKL; Cuneo BF; Cohen RE; Robins K; Masson M; Wainwright BJ; Zahr N; Saxena A; Buyon JP
    J Am Coll Cardiol; 2020 Jul; 76(3):292-302. PubMed ID: 32674792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
    Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
    Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry.
    Buyon JP; Hiebert R; Copel J; Craft J; Friedman D; Katholi M; Lee LA; Provost TT; Reichlin M; Rider L; Rupel A; Saleeb S; Weston WL; Skovron ML
    J Am Coll Cardiol; 1998 Jun; 31(7):1658-66. PubMed ID: 9626848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Congenital heart block associated with maternal anti SSA/SSB antibodies :a report of four cases].
    Ayed K; Gorgi Y; Sfar I; Khrouf M
    Pathol Biol (Paris); 2004 Apr; 52(3):138-47. PubMed ID: 15063933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neonatal lupus syndrome: Literature review].
    Morel N; Georgin-Lavialle S; Levesque K; Guettrot-Imbert G; Le Guern V; Le Bidois J; Bessières B; Brouzes C; Le Mercier D; Villain E; Maltret A; Costedoat-Chalumeau N
    Rev Med Interne; 2015 Mar; 36(3):159-66. PubMed ID: 25240481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
    Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
    J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antenatal and postnatal combined therapy for autoantibody-related congenital atrioventricular block.
    Di Mauro A; Caroli Casavola V; Favia Guarnieri G; Calderoni G; Cicinelli E; Laforgia N
    BMC Pregnancy Childbirth; 2013 Nov; 13():220. PubMed ID: 24286473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital heart block in neonatal lupus: the pediatric cardiologist's perspective.
    Friedman DM; Rupel A; Glickstein J; Buyon JP
    Indian J Pediatr; 2002 Jun; 69(6):517-22. PubMed ID: 12139139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies.
    Buyon JP; Winchester RJ; Slade SG; Arnett F; Copel J; Friedman D; Lockshin MD
    Arthritis Rheum; 1993 Sep; 36(9):1263-73. PubMed ID: 8216420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significantly increased maternal and fetal IgG autoantibody levels to 52 kD Ro (SS-A) and La(SS-B) in complete congenital heart block.
    Dörner T; Chaoui R; Feist E; Göldner B; Yamamoto K; Hiepe F
    J Autoimmun; 1995 Oct; 8(5):675-84. PubMed ID: 8579723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.
    Mevorach D; Elchalal U; Rein AJ
    Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study.
    Friedman DM; Kim MY; Copel JA; Davis C; Phoon CK; Glickstein JS; Buyon JP;
    Circulation; 2008 Jan; 117(4):485-93. PubMed ID: 18195175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing congenital neonatal heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and registered clinical trials.
    Gleicher N; Elkayam U
    Autoimmun Rev; 2013 Sep; 12(11):1039-45. PubMed ID: 23684701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmapheresis, intravenous immunoglobulins and bethametasone - a combined protocol to treat autoimmune congenital heart block: a prospective cohort study.
    Ruffatti A; Cerutti A; Favaro M; Del Ross T; Calligaro A; Hoxha A; Marson P; Leoni L; Milanesi O
    Clin Exp Rheumatol; 2016; 34(4):706-13. PubMed ID: 27385463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired congenital heart block. Pattern of maternal antibody response to biochemically defined antigens of the SSA/Ro-SSB/La system in neonatal lupus.
    Buyon JP; Ben-Chetrit E; Karp S; Roubey RA; Pompeo L; Reeves WH; Tan EM; Winchester R
    J Clin Invest; 1989 Aug; 84(2):627-34. PubMed ID: 2760204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.